Entecavir+Fuzheng Huayu+TCM Granule
SGHLC20140818002
Approved small_molecule active
Quick answer
Entecavir+Fuzheng Huayu+TCM Granule for Hepatitis B Virus Related Cirrhosis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hepatitis B Virus Related Cirrhosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active